Epstein-barr Virus Negative Primary Central Nervous System Lymphoma Developed after Treatment of Glioblastoma: A Case Report

Temozolomide is an oral alkylating agent with moderate side effects compared to other agents. However, the development of secondary malignancies following temozolomide has been reported. We describe the first case of primary central nervous system lymphoma (PCNSL) occurrence following glioblastoma t...

Descripción completa

Detalles Bibliográficos
Autores principales: KHAIRUNNISA, Novita Ikbar, YAMASAKI, Fumiyuki, AMATYA, Vishwa Jeet, TAKAYASU, Takeshi, YONEZAWA, Ushio, TAGUCHI, Akira, ONISHI, Shumpei, HORIE, Nobutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719745/
https://www.ncbi.nlm.nih.gov/pubmed/36518906
http://dx.doi.org/10.2176/jns-nmc.2022-0228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719745/
https://www.ncbi.nlm.nih.gov/pubmed/36518906
http://dx.doi.org/10.2176/jns-nmc.2022-0228

Ejemplares similares